Status:
COMPLETED
New Heart Failure Biomarkers in Early Stage Chronic Kidney Disease-Mineral and Bone Disorder
Lead Sponsor:
Pr. Semir Nouira
Conditions:
Kidney Disease, Chronic
Heart Failure
Eligibility:
All Genders
18-90 years
Brief Summary
the objective of this study is to : -Determinate wether the circulating levels of iFGF23 and klotho can be a predictor biomarker of HF in patients with CKD-MBD.
Detailed Description
The disorders of mineral metabolism and bone disease are common complications in CKD patients and they are associated with increased morbidity and mortality. Abnormalities of the vasculature are seen...
Eligibility Criteria
Inclusion
- Early CKD stage
- Heart failure
Exclusion
- Infections
- cancer
- corticoid therapy
- renal replacement therapy
- Advanced CKD stage
Key Trial Info
Start Date :
June 15 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2015
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT03307707
Start Date
June 15 2015
End Date
December 30 2015
Last Update
October 12 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.